Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Merrimack Pharmaceuticals Inc (MACK)

8.61 0.12 (1.41%)

05-25 16:00

Open:

8.47

Pre. Close:

8.49

High:

8.63

Low:

8.44

Volume:

41,719

Market Cap:

115M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.642 - 8.691

8.691 - 8.735

Low:

8.311 - 8.375

8.375 - 8.434

Close:

8.517 - 8.61

8.61 - 8.695

Technical analysis  (as of: 2018-05-25 4:36:53 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 10.18     One year: 10.56

Support:

Support1: 8.20    Support2: 6.82

Resistance:

Resistance1: 8.72    Resistance2: 9.04

Pivot:

8.66

Moving Averages:

MA(5): 8.63     MA(20): 8.68

MA(100): 9.73     MA(250): 11.55

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.04

%K %D:

%K(14,3): 43.92     %D(3): 47.29

RSI:

RSI(14): 47.47

52-Week:

High: 24.7  Low: 7.37  Change(%): -63.7

Average Vol(K):

3-Month: 13899  10-Days 5987

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
MACK has closed above bottom band by 40.2%. Bollinger Bands are 63.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to MACK's normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-08T09:52:06-04:00
Merrimack Pharmaceuticals' (MACK) CEO Richard Peters on Q1 2018 Results - Earnings Call Transcript

2018-05-08T06:25:00-04:00
Merrimack Reports First Quarter 2018 Financial Results

2018-05-01T07:00:00-04:00
Merrimack Announces Timing of First Quarter 2018 Investor Conference Call

2018-04-19T12:19:45-04:00
Merrimack Pharmaceuticals Potential Catalyst A Likely Bust

2018-04-09T07:30:00-04:00
Merrimack to Present Preclinical Data at the 2018 American Association for Cancer Research Annual Meeting

2018-03-13T17:27:17-04:00
Your Daily Pharma Scoop: Portola's New Interim Data, Lantheus Announces Promising Data For LMI 1195, Kura Tumbles On Update

2018-03-12T14:31:42-04:00
Merrimack Pharma down 10% on expanded enrollment in mid-stage study of MM-121

2018-03-12T12:45:10-04:00
Midday Gainers / Losers (3/12/2018)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

13.34

Shares Float (M)

5.08

% Held by Insiders

61.90

% Held by Institutions

59.30

Shares Short (K)

1674

Shares Short Prior Month (K)

1800

Stock Financials

EPS

-4.820

EPS Est. Current Year

33.490

EPS Est. Next Year

-14.050

EPS Est. Next Quarter

-1.360

Forward EPS

-3.932

Book Value (p.s.)

1.410

PEG Ratio

-0.32

Profit Margin

Operating Margin

Return on Assets (ttm)

582.6

Return on Equity (ttm)

-492.6

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.795

Qtrly Earnings Growth

Operating Cash Flow (M)

-153.12

Levered Free Cash Flow (M)

-118.91

atoplab.com

Valuation

P/E

-1.79

P/E Growth Ratio

0.01

P/BV

6.11

P/S

P/CF

-0.75

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2017-05-26

Ex-Dividend Date

2017-05-30

Forward Dividend

Last Split Date

2017-09-06

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.